These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1345535)

  • 1. Prolactin and LH release in response to vasoactive intestinal peptide (VIP) administration in spontaneously hypertensive and normotensive rats.
    Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Staff-Zielińska E; Kochman K
    Endokrynol Pol; 1992; 43(2):137-44. PubMed ID: 1345535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influences of GnRH, oxytocin and vasoactive intestinal peptide on LH and PRL secretion by porcine pituitary cells in vitro.
    Bogacka I; Siawrys G; Okrasa S; Kaminski T; Przala J
    J Physiol Pharmacol; 2002 Sep; 53(3):439-51. PubMed ID: 12369740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The peak phase of the proestrous prolactin surge is blocked by either posterior pituitary lobectomy or antisera to vasoactive intestinal peptide.
    Murai I; Reichlin S; Ben-Jonathan N
    Endocrinology; 1989 Feb; 124(2):1050-5. PubMed ID: 2492217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin gene expression and secretion during pregnancy and lactation in the rat: role of dopamine and vasoactive intestinal peptide.
    Escalada J; Cacicedo L; Ortego J; Melian E; Sánchez-Franco F
    Endocrinology; 1996 Feb; 137(2):631-7. PubMed ID: 8593812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of passive immunization against vasoactive intestinal peptide on serum prolactin and LH levels.
    Lasaga M; Debeljuk L; Afione S; Aleman IT; Duvilanski B
    Neuroendocrinology; 1989 Jun; 49(6):574-9. PubMed ID: 2770978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ovine prolactin administration on hypothalamic vasoactive intestinal peptide (VIP), gonadotropin releasing hormone I and II content, and anterior pituitary VIP receptors in laying turkey hens.
    Rozenboim I; Tabibzadeh C; Silsby JL; el Halawani ME
    Biol Reprod; 1993 Jun; 48(6):1246-50. PubMed ID: 8391330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The control of circadian rhythms and the levels of vasoactive intestinal peptide mRNA in the suprachiasmatic nucleus are altered in spontaneously hypertensive rats.
    Peters RV; Zoeller RT; Hennessey AC; Stopa EG; Anderson G; Albers HE
    Brain Res; 1994 Mar; 639(2):217-27. PubMed ID: 8205475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LH and PRL secretion in ovariectomized spontaneously hypertensive rats.
    Hashimoto R; Arita J; Kimura F
    Acta Endocrinol (Copenh); 1990 Apr; 122(4):540-4. PubMed ID: 2333738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal peptide inhibits luteinizing hormone secretion: the inhibition is not mediated by dopamine.
    Stobie KM; Weick RF
    Neuroendocrinology; 1989 Jun; 49(6):597-603. PubMed ID: 2671777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide in the hypothalamus and pituitary.
    Lam KS
    Neuroendocrinology; 1991; 53 Suppl 1():45-51. PubMed ID: 1901391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxytocin mediates the hypothalamic action of vasoactive intestinal peptide to stimulate prolactin secretion.
    Samson WK; Bianchi R; Mogg RJ; Rivier J; Vale W; Melin P
    Endocrinology; 1989 Feb; 124(2):812-9. PubMed ID: 2912703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal peptide stimulates gonadotropin-releasing hormone release from rat hypothalamus in vitro.
    Ohtsuka S; Miyake A; Nishizaki T; Tasaka K; Tanizawa O
    Acta Endocrinol (Copenh); 1988 Mar; 117(3):399-402. PubMed ID: 3289303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
    Balsa JA; Sánchez-Franco F; Lorenzo MJ; Pazos F; Lara JI; Cacicedo L
    Endocrinology; 1996 Feb; 137(2):508-13. PubMed ID: 8593796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional brain concentrations of vasoactive intestinal polypeptide in normotensive Wistar-Kyoto and spontaneously hypertensive rats.
    Lewis SJ; Shulkes A; Jarrott B
    Brain Res; 1986 Dec; 399(1):173-7. PubMed ID: 3801918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal polypeptide effects a central inhibition of pulsatile luteinizing hormone secretion in ovariectomized rats.
    Alexander MJ; Clifton DK; Steiner RA
    Endocrinology; 1985 Nov; 117(5):2134-9. PubMed ID: 3899617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal polypeptide (VIP) selectively stimulates prolactin release in healthy women.
    Falsetti L; Zanagnolo V; Gastaldi A; Memo M; Missale C; Spano PF
    Gynecol Endocrinol; 1988 Mar; 2(1):11-8. PubMed ID: 3140588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal peptide can modulate immune and endocrine responses during lipopolysaccharide-induced acute inflammation.
    Bik W; Wolinska-Witort E; Chmielowska M; Baranowska-Bik A; Rusiecka-Kuczalek E; Baranowska B
    Neuroimmunomodulation; 2004; 11(6):358-64. PubMed ID: 15467350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prostaglandin E1 on vasoactive intestinal polypeptide release from the hypothalamus and on prolactin secretion from the pituitary in rats.
    Shimatsu A; Kato Y; Matsushita N; Katakami H; Ohta H; Yanaihara N; Imura H
    Endocrinology; 1983 Dec; 113(6):2059-64. PubMed ID: 6685619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential induction of c-fos immunoreactivity in vasoactive intestinal polypeptide-innervated gonadotropin-releasing hormone neurons during a steroid-induced luteinizing hormone surge in the female rat.
    van der Beek EM; van Oudheusden HJ; Buijs RM; van der Donk HA; van den Hurk R; Wiegant VM
    Endocrinology; 1994 Jun; 134(6):2636-44. PubMed ID: 8194489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential increase in pituitary prolactin versus vasoactive intestinal peptide as a function of estradiol benzoate dose in the ovariectomized rat.
    Carrillo AJ; Doherty PC; Guan XB; Sturtevant JR; Walro DG
    Endocrinology; 1991 Jan; 128(1):131-8. PubMed ID: 1986914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.